Putnam, a leader in the life sciences strategic advisory services, congratulates Yuanfei Wang and Joanne Evason on their promotions to Partner.
It is an exciting time to be part of the firm – with continued growth on the horizon. Putnam leadership could not be more thrilled to welcome Joanne and Yuanfei to the leadership team. This is an incredible milestone in their careers – and one they are both so deserving of.
Yuanfei has experienced an impressive journey through Putnam, starting in 2014 as a Life Sciences Consultant – just one of the first classes of Putnam LSCs. Her educational background includes a PhD in Chemical and Biomedical Engineering from the University of Toronto. Prior to Yuanfei joining Putnam, she spent two years in a small venture/ strategy consulting firm, Fletcher Spaght. Currently at Putnam, she is focused on building a practice of innovative commercial-data hybrid offerings – where the team applies novel analytical approaches to a combination of data sources (both big data and primary market research) to answer complex strategic questions.
Yuanfei is a role model for Putnam’s consultants, showing the meaning of hard work and determination. When asked what she is most excited for as Partner, she shares the meaningful opportunity that comes with the role in delivering value for clients and continuously pushing the boundaries on service offerings, underscored by Putnam’s mission to help their clients solve the most complex and challenging problems. She adds, “Most importantly, I’m looking forward to continuing to help maintain our incredible culture while driving growth and foster future leaders for our organization with the incredible talent group that we have.”
Joanne joined Putnam about two years ago, bringing 18 years of experience in life sciences, both industry and consulting. After being part of some great firms including Pfizer, GSK, IQVIA, gaining a breadth and depth of expertise, Joanne knew she wanted something very specific. She is part of Putnam’s VPA (value, pricing, and access) practice – an area where much of her experience stems. For example, she has focused on leveraging RWE to solve VPA problems, linking in the policy angle, and working with clients to drive patient access to some of the most transformational therapeutics at the global level, along with developing depth of expertise in key European markets.
Joanne brings deep knowledge and strong leadership qualities to the firm and is an integral part of the VPA leadership team. While reflecting on her experience at Putnam, she shares, “Joining the VPA practice at Putnam has been incredible, led by Eric Auger, and a strong, experienced leadership team, we focus on some of the most challenging VPA problems in the industry, and have continued to grow across a broader geography, with the expansion of our European team.” She is excited for what’s next and is looking forward to the continued journey ahead in her new role.
Yuanfei and Joanne’s contributions to Putnam’s business, teams, and clients have been invaluable. Putnam leadership is looking forward to supporting their continued success and future accomplishments. The broader employee community wishes Joanne and Yuanfei their sincerest congratulations.
Putnam also celebrates several promotions across the firm this month:
- Gerardo Perla – Senior Associate Consultant
- Jamie Swotes – Consultant
- Ethan Johnson – Senior Consultant
- Mitchell Koganski – Senior Associate Consultant
- Lance Yassay – Consultant
- Hayden Gruber – Senior Consultant
- Mitesh Bhalani – Senior Associate Consultant
- Trisha Bhatia – Consultant
- Aidan Cassidy – Senior Consultant
- Ross Mulford – Senior Associate Consultant
- Benjamin Derleth – Consultant
- Brock Staskawicz – Senior Consultant
- Jeff Liu – Consultant
- Ann Wechsler – Consultant
- Alexandra Hecht – Senior Consultant
- Alexus Sorina – Consultant
- Madeleine Chase – Consultant
- Eric Yang – Manager
- Amalia Roth – Consultant
- Dian Huang – Senior Consultant
- Maria Aviles – Sr. Manager of Pharmacovigilance & Market Research Compliance
Putnam is a premier strategy consulting firm serving biopharmaceutical, diagnostics, medtech, and private equity / venture capital clients. For over 30 years, we have provided objective, high impact strategic advice and analytical services, helping to support clients in crucial business decisions at all stages of the product and franchise lifecycle. We are proudly part of Inizio Advisory, an ecosystem of healthcare advisory businesses offering the finest depth of expertise you need, all under one roof.